Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-056986

Director sold 10,000 shares at $131.71 ($1,317,100)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BEHRENS M KATHLEEN · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-10-31 Exercise or conversion : show line 1 in the form +10,000 $3.96 $39,600 126,534 D
2018-10-31 Sale : show line 2 in the form −10,000 $131.71 $1,317,100 116,534 D
Open-market sales · 10,000 sh · avg $131.71 · $1,317,100

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-10-31 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −10,000 $3.96 2019-03-31 10,000 0 D
Loading xslF345X03/doc4.xml…